Sort
8,912 grants matching “sars cov 2”
Washington National Primate Research Center
$12,987,645Mari Ostendorf · University Of Washington · P51 · FY2024 · OD
Washington National Primate Research Center
$12,987,644Mari Ostendorf · University Of Washington · P51 · FY2022 · OD
RADX TECH 2375 - POINT OF NEED, SALIVA-BASED, COVID-19 TESTING PLATFORMS
$12,970,000Dave Beebe · Flambeau Diagnostics Llc · N02 · FY2022 · HL
Washington National Primate Research Center
$12,968,296Mari Ostendorf · University Of Washington · P51 · FY2023 · OD
RADx-UP CDCC
$12,729,140Michael Cohen-Wolkowiez · Duke University · U24 · FY2023 · MD
CoVPN 3008 2022-2023
$12,647,369Peter B. Gilbert · Fred Hutchinson Cancer Center · UM1 · FY2023 · AI
Structural and chemical biology of membrane proteins
$12,607,429Anirban Banerjee · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
Advancing genomic, transcriptomic and functional approaches to combat globally important and emerging pathogens
$12,121,843Daniel E Neafsey · Broad Institute, Inc. · U19 · FY2024 · AI
Discovering Durable Pan-Coronavirus Immunity
$11,809,995Duane R. Wesemann · Brigham And Women'S Hospital · P01 · FY2021 · AI
RAPID ACCELERATION OF DIAGNOSTICS (RADX) PROGRAM TECH PROJECT #7697: SARS-COV-2 AG HOME TEST
$11,764,515Andrew Wheeler · Mologic Inc. · N02 · FY2021 · HL
Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site:21-0011
$11,669,935Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2021 · AI
THIS IS A CONTRACT AWARD FOR VENTUREWELL TO PROVIDE SUPPORT FOR TECHNICAL ASSESSMENTS AND PROJECT MANAGEMENT FOR THE NIBIB RAPID ACCELERATION OF DIAGN
$11,288,096Mark Marino · Venturewell · N02 · FY2021 · HL
MICROBIOLOGY AND INFECTIOUS DISEASES BIOLOGICAL RESEARCH REPOSITORY (MID BRR) - SARS-CoV-2 THERAPEUTICS RESEARCH RELATED ACTIVITIES
$11,000,208Timothy Stedman · American Type Culture Collection · N01 · FY2021 · AI
Research Services Core (RSC)
$10,999,069Samuel Michael · National Center For Advancing Translational Sciences · ZIC · FY2021 · TR
Asthma and Allergic Diseases Group
$10,601,507Samuel Arbes · Rho Federal Systems Division, Inc. · UM2 · FY2020 · AI
Rho Federal Systems Division, Inc. NIAID DAIT SACCC
$10,601,507Gloria David · Rho Federal Systems Division, Inc. · UM2 · FY2020 · AI
Core B â Medicinal and Process Chemistry
$10,548,554Michael George Natchus · Emory University · U19 · FY2022 · AI
Design and Development of a Pan-betacoronavirus Vaccine
$10,478,045Barton F Haynes · Duke University · P01 · FY2023 · AI
Development of a SARS Coronavirus Vaccine
$10,427,728Novartis Vaccines And Diagnostics, Inc. · UC1 · FY2004 · AI
Inter- and Intra-Species Comparative Sequencing
$10,295,725James C Mullikin · National Human Genome Research Institute · ZIB · FY2022 · HG
RAPID ACCELERATION OF DIAGNOSTICS (RADX) TECH PROGRAM - PROJECT #6658
$10,295,000David Yoo · Genbody Inc. · N02 · FY2021 · HL
Convalescent Plasma to Limit Coronavirus Associated Complications
$9,843,178David D McPherson · University Of Texas Hlth Sci Ctr Houston · UL1 · FY2021 · TR
RAPID ACCELERATION OF DIAGNOSTICS ( RADX) PROGRAM: TECH PROJECT #2322 MICROGEM (MICROLAB)
$9,806,000Stuart Hellyar Hellyar · · N02 · FY2022 · HL
Inter- and Intra-Species Comparative Sequencing
$9,768,240James C Mullikin · National Human Genome Research Institute · ZIB · FY2021 · HG
Applied Clinical Informatics
$9,759,877James Mork · National Library Of Medicine · ZIH · FY2022 · LM